Correction: Reversible posterior leukoencephalopathy syndrome (RPLS) in a patient with chronic lymphocytic leukemia (CLL) treated with Acalabrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor: a case report
本文未提供摘要,请点击“查看全文”查看完整内容。